ADM unveils supportive solutions for GLP-1 users

By 2024-10-09T15:07:46

ADM introduces a new platform offering tailored nutritional solutions for consumers using GLP-1 and other anti-obesity medications. The initiative aims to address the unique dietary needs of this growing segment, as market projections for AOMs approach £100 billion by 2030.

Already a member? Sign-in

Unlock

Next generation intelligence for smarter, safer food production

At New Food, our mission is to deliver trusted intelligence that supports innovation for smarter, safer and more sustainable food production. We connect science, regulation and industry expertise to help food professionals transform global food systems for the better.

Become a member to continue reading

By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:

  • Unlimited access to industry intelligence that can make a difference to your business
  • A weekly newsletter keeping the most vital information at the front of your thinking
  • Exclusive invitations to powerful webinars and events featuring high profile experts
  • Access to deep-dive reports and analysis that reveal exciting new opportunities for business growth and transformation

Become a member